Tuesday, April 6, 2021
9 am – 1 pm
Through the generous and continued support of Gloria and Mark Snyder, each year we are able to bring together a group of exceptional internal and external speakers with expertise in a number of exciting areas of cancer research.
This year, Stony Brook University Cancer Center’s Oncogenic Drivers and Mechanisms of Carcinogenesis (ODMC) Research Program, the Office of Community Outreach and Engagement and the Population Sciences Program, are working in partnership to host the virtual symposium, which will focus on “Innovative Discovery in Cancer Population Science to Improve Public Health.”
We are especially delighted to welcome our two keynote speakers Dr. Electra D. Paskett, PhD, from Ohio State University and John P.A. Ioannidis, MD, DSc, from Stanford University: two world leaders in population research and cancer control.
This year’s Symposium will also highlight research from scientist members of the ODMC program conducting research in these areas and the outstanding research activities of our students and postdoctoral fellows.
The impact of Stony Brook Cancer Center’s population science activities is truly reflective of the global collaborative efforts that go far beyond Long Island.
On behalf of Stony Brook Cancer Center and the 2021 Gloria and Mark Snyder Symposium Organizing Committee, we hope you enjoy this event and that you are inspired in your own cancer research.
2021 Symposium: Innovative Discovery in Cancer Population Science to Improve Public Health
The topics will cover:
- A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia
- Reproducible and Useful Evidence for Cancer Prevention
- Cancer Prevention: A Global Perspective
- Evaluation of K17 as a Prognostic and Predictive Biomarker for Pancreatic Cancer
- Molecular Epidemiology of Aristolochic Acid, an Environmental Carcinogen
- Evaluation of Factors Contributing to ALL Treatment-Associated Obesity in a Multi-ethnic Pediatric Patient Population
|9 – 9:10 am||Welcome remarks|
|9:10 – 10:25 am||Session I|
|10:25 – 10:30 am||Break|
|10:30am – Noon||Keynote Speakers|
|Noon – 1pm||Poster session|
|Electra Diane Paskett, PhD||
Marion N. Rowley Professor of Cancer Research and
Director, Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine
Professor, Division of Epidemiology, College of Public Health
Director, Center for Cancer Health Equity, James Cancer Hospital Ohio State University
Dr. Paskett is a professor and director of the Division of Cancer Prevention and Control in the Department of Internal Medicine at The Ohio State University College of Medicine, where she holds the Marion N. Rowley Designated Chair in Cancer Research. She also serves as the associate director for population sciences and community outreach, co-leader of the Cancer Control Program and director of the Diversity Enhancement Program at the OSUCCC – James.
Dr. Paskett’s research program is nationally recognized for studying cancer health disparities. Through her research, she finds ways to help others prevent or reduce the burden of cancer by designing intervention strategies that persuade people to change their behavior and take control of their health. Some of her recent work focuses on intervention studies directed at cancer prevention, early detection and survivorship issues, specifically among underserved populations.
Dr. Paskett leads several grant-funded projects, and has published extensively in prestigious scientific journals. She was a past president of the American Society of Preventive Oncology, which created a scholarship in her name to honor her highly successful two-year term as leader of that multidisciplinary society.
|John P.A. Ioannidis, MD, DSc||
Professor of Medicine, of Epidemiology and Population Health,
and (by courtesy) of Biomedical Data Science, Stanford University School of Medicine
Professor (by courtesy) of Statistics, Stanford University of Humanities and Sciences
Co-Director, Meta-Research Innovation Center at Stanford (METRICS), Stanford University
Einstein Fellow and Director, Meta-Research Innovation Center Berlin
Dr. Ioannidis trained at the University of Athens School of Medicine in Greece, Harvard Medical School and Tufts University School of Medicine. He has held appointments at the U.S. National Institutes of Health, Johns Hopkins University, Tufts University, Harvard University, Imperial College in London, and the University of Ioannina, before moving to Stanford University in 2010.
Dr. Ioannidis is one of the most-cited scientists of all times in the scientific literature. His current research at Stanford covers a wide agenda, including meta-research, large-scale evidence, population health sciences and predictive medicine and health. He has received numerous awards, including:
He has been awarded honorary titles from FORTH (2014) and Ioannina (2015), and honorary doctorates from 5 universities, as well as multiple honorary lectureships/visiting professorships. He has been inducted into the U.S. National Academy of Medicine, the European Academy of Sciences and Arts, the Association of American Physicians, the American Epidemiological Society, the European Academy of Cancer Sciences, and the Academy of Sciences of Bologna.
Dr. Ioannidis is recognized as the leading clinical research methodologist of his generation for his work in evidence-based medicine and in appraising and improving the credibility of scientific studies and results. The PLoS Medicine article, “Why Most Published Research Findings are False,” was the most accessed and downloaded article in the history of PLoS. The Atlantic selected Dr. Ioannidis as the Brave Thinker scientist for 2010, characterizing him as one of the most influential scientists alive.